Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

XPO1 inhibition by selinexor induces potent cytotoxicity against high grade bladder malignancies.

Autor: Baek HB; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Lombard AP; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.; Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Group and Biotechnology Program, University of California Davis, Davis, CA, USA., Libertini SJ; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Fernandez-Rubio A; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Vinall R; California Northstate College of Pharmacy, Elk Grove, CA, USA., Gandour-Edwards R; Department of Pathology and Laboratory Medicine, University of California Davis, Sacramento, CA, USA., Nakagawa R; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Vidallo K; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Nishida K; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA., Siddiqui S; Veterans Affairs-Northern California Health Care System, Mather, CA, USA., Wettersten H; Department of Internal Medicine, University of California Davis, Davis, CA, USA., Landesman Y; Karyopharm Therapeutics, Newton, MA, USA., Weiss RH; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Internal Medicine, University of California Davis, Davis, CA, USA., Ghosh PM; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Urology, University of California Davis, Sacramento, CA, USA., Mudryj M; Veterans Affairs-Northern California Health Care System, Mather, CA, USA.; Department of Medical Microbiology and Immunology, University of California Davis, Davis, CA, USA.

Publikováno v: Oncotarget [Oncotarget] 2018 Oct 02; Vol. 9 (77), pp. 34567-34581. Date of Electronic Publication: 2018 Oct 02 (Print Publication: 2018).